Cure8 trial brief
Why This Matters
Exercise programs could be a low-risk way to improve activity levels, reduce fear of movement, and enhance quality of life for people with Crohn’s disease or ulcerative colitis if the trial shows benefit.
Who Should Pay Attention
Adults with IBD interested in exercise interventions; physiotherapists and clinicians advising IBD patients; researchers in lifestyle and rehabilitation for IBD.
Study Snapshot
What To Know
This is an interventional, randomized study planned to enroll about 150 adults with confirmed IBD and is currently listed as not yet recruiting. Participants are randomized to one of three arms: a Pilates program, a combined resistance-and-aerobic training program, or a control group.
Exercise sessions are 20–30 minutes, twice weekly for 12 weeks, and adherence will be tracked with exercise diaries. Outcomes include change in kinesiophobia (Tampa Scale of Kinesiophobia) and multiple patient-reported measures (physical activity, quality of life, depressive symptoms, knowledge/attitudes about physical activity).
Keep In Mind
This entry is a ClinicalTrials.gov registration (trial record) and reports planned methods and outcomes but does not present results. Recruitment status is NOT_YET_RECRUITING.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.